These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 8751893)

  • 1. Experimental vaccination against group B streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and alpha.
    Larsson C; Stålhammar-Carlemalm M; Lindahl G
    Infect Immun; 1996 Sep; 64(9):3518-23. PubMed ID: 8751893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections.
    Stålhammar-Carlemalm M; Stenberg L; Lindahl G
    J Exp Med; 1993 Jun; 177(6):1593-603. PubMed ID: 8496678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine.
    Larsson C; Stålhammar-Carlemalm M; Lindahl G
    Vaccine; 1999 Feb; 17(5):454-8. PubMed ID: 10073723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal immunization of mice with group B streptococcal protein rib and cholera toxin B subunit confers protection against lethal infection.
    Larsson C; Holmgren J; Lindahl G; Bergquist C
    Infect Immun; 2004 Feb; 72(2):1184-7. PubMed ID: 14742572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group B streptococcal surface proteins as targets for protective antibodies: identification of two novel proteins in strains of serotype V.
    Areschoug T; Stålhammar-Carlemalm M; Larsson C; Lindahl G
    Infect Immun; 1999 Dec; 67(12):6350-7. PubMed ID: 10569749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines.
    Gravekamp C; Kasper DL; Paoletti LC; Madoff LC
    Infect Immun; 1999 May; 67(5):2491-6. PubMed ID: 10225912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-protection between group A and group B streptococci due to cross-reacting surface proteins.
    Stâlhammar-Carlemalm M; Areschoug T; Larsson C; Lindahl G
    J Infect Dis; 2000 Jul; 182(1):142-9. PubMed ID: 10882591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with highly purified cell surface proteins confers protection against experimental group B streptococcal infection.
    Larsson C; Stålhammar-Carlemalm M; Lindahl G
    Adv Exp Med Biol; 1997; 418():851-3. PubMed ID: 9331786
    [No Abstract]   [Full Text] [Related]  

  • 9. Association between low concentrations of antibodies to protein alpha and Rib and invasive neonatal group B streptococcal infection.
    Larsson C; Lindroth M; Nordin P; Stålhammar-Carlemalm M; Lindahl G; Krantz I
    Arch Dis Child Fetal Neonatal Ed; 2006 Nov; 91(6):F403-8. PubMed ID: 17056838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant group B Streptococcus alpha-like protein 3 is an effective immunogen and carrier protein.
    Yang HH; Mascuch SJ; Madoff LC; Paoletti LC
    Clin Vaccine Immunol; 2008 Jul; 15(7):1035-41. PubMed ID: 18463225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonimmunodominant regions are effective as building blocks in a streptococcal fusion protein vaccine.
    Stålhammar-Carlemalm M; Waldemarsson J; Johnsson E; Areschoug T; Lindahl G
    Cell Host Microbe; 2007 Dec; 2(6):427-34. PubMed ID: 18078694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a universal Group B streptococcus vaccine by multiple genome screen.
    Maione D; Margarit I; Rinaudo CD; Masignani V; Mora M; Scarselli M; Tettelin H; Brettoni C; Iacobini ET; Rosini R; D'Agostino N; Miorin L; Buccato S; Mariani M; Galli G; Nogarotto R; Nardi-Dei V; Vegni F; Fraser C; Mancuso G; Teti G; Madoff LC; Paoletti LC; Rappuoli R; Kasper DL; Telford JL; Grandi G
    Science; 2005 Jul; 309(5731):148-50. PubMed ID: 15994562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of group B protective surface protein, a new cell surface protective antigen of group B streptococci.
    Erdogan S; Fagan PK; Talay SR; Rohde M; Ferrieri P; Flores AE; Guzmán CA; Walker MJ; Chhatwal GS
    Infect Immun; 2002 Feb; 70(2):803-11. PubMed ID: 11796614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection from group B streptococcal infection in neonatal mice by maternal immunization with recombinant Sip protein.
    Martin D; Rioux S; Gagnon E; Boyer M; Hamel J; Charland N; Brodeur BR
    Infect Immun; 2002 Sep; 70(9):4897-901. PubMed ID: 12183534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed Conjugation.
    Nilo A; Morelli L; Passalacqua I; Brogioni B; Allan M; Carboni F; Pezzicoli A; Zerbini F; Maione D; Fabbrini M; Romano MR; Hu QY; Margarit I; Berti F; Adamo R
    ACS Chem Biol; 2015 Jul; 10(7):1737-46. PubMed ID: 25906283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and protective activity in animals of a type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
    Wessels MR; Paoletti LC; Pinel J; Kasper DL
    J Infect Dis; 1995 Apr; 171(4):879-84. PubMed ID: 7706814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temperature-Induced Self-Assembly of the Group B Streptococcus (GBS) Fusion Antigen GBS-NN.
    Rose F; Roovers S; Fano M; Harloff-Helleberg S; Kirkensgaard JJK; Hejnaes K; Fischer P; Foged C
    Mol Pharm; 2018 Jul; 15(7):2584-2593. PubMed ID: 29745668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant group B streptococcus Beta C protein and a variant with the deletion of its immunoglobulin A-binding site are protective mouse maternal vaccines and effective carriers in conjugate vaccines.
    Yang HH; Madoff LC; Guttormsen HK; Liu YD; Paoletti LC
    Infect Immun; 2007 Jul; 75(7):3455-61. PubMed ID: 17470542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine.
    Paoletti LC; Wessels MR; Rodewald AK; Shroff AA; Jennings HJ; Kasper DL
    Infect Immun; 1994 Aug; 62(8):3236-43. PubMed ID: 8039893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes.
    Madoff LC; Paoletti LC; Tai JY; Kasper DL
    J Clin Invest; 1994 Jul; 94(1):286-92. PubMed ID: 7518832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.